Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody (Q79795066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

12

Jiannan Feng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Chao Bian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Xiuqin Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Xingfeng Cai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Linqi Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ye Zha

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ying Xu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ke Xu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Wei Lu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Linchen Yan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jianwei Yuan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Pei Hao

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Qidi Wang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Guoping Zhao

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gang Liu

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Xueliang Zhu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Hao Shen

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bojian Zheng

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Beifen Shen

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bing Sun

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

4 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

39-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

SARS-Associated Coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

SARS--beginning to understand a new virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.09.029

10.1016/J.VIROL.2008.09.029

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986662%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference